Paris, 27 February 2018
In its response to a public consultation by the European Medicines Agency on initiatives for electronic EU product information, Prescrire recognises the interest of improved access to updated patient leaflets. However, such new initiatives should not lead to direct-to-consumer advertising (DTCA).
> Download Prescrire's contribution (pdf, 67 Ko)
©Prescrire February 2018
Partager |
 |
 |